Adverum Biotechnologies is a gene therapy company focused on developing treatments for ocular and rare diseases. Its lead product candidate, ADVM-022, is a gene therapy used to treat chronic retinal diseases. The company has license and collaboration agreements with various institutions and was formerly known as Avalanche Biotechnologies. It was founded in 2006 and is based in Redwood City, California.